Cardiac operation and interventional therapy during pregnancy： an analysis of outcome
10.3760/cma.j.cn112141-20200128-00064
- VernacularTitle:妊娠期心脏病孕妇手术及介入治疗结局分析
- Author:
Yanli LIU
1
;
Fengzhen HAN
;
Jian ZHUANG
;
Huanlei HUANG
;
Caojin ZHANG
;
Haojian DONG
;
Chengbin ZHOU
Author Information
1. 广东省人民医院（广东省医学科学院）产科， 广州 510080
- From:
Chinese Journal of Obstetrics and Gynecology
2020;55(7):465-470
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the efficacy and safety of open cardiac operation and interventional therapy in pregnant patients and describe the feto-neonatal and maternal outcomes.Methods:A retrospective study of 39 cases of women undergoing open cardiac operation or interventional therapy during pregnancy was conducted in Guangdong Provincial People′s Hospital from Jan. 2014 to Oct. 2019.Results:The age of 39 pregnant women with gestational heart disease was (30±6) years old (21-43 years old). Among them, 37 cases were single and 2 cases were twin pregnancy. Modified World Health Organization (mWHO) pregnancy risk classification were all level Ⅳ. There were 22 women receiving cardiac operation under cardiopulmonary bypass during pregnancy, 14 patients undergoing percutaneous balloon mitral valvuloplasty, 2 patients accepting percutaneous balloon pulmonary valvuloplasty, and 1 case receiving atrial septal defect occluder with ultrasound guidance. Three were no maternal deaths during and after the operation. One patient had an inevitable abortion. Four fetuses died in the uterine after open cardiac surgery. There patients chose termination of the pregnancy after cardiac operation. There were 31 live birth, in which 7 cases were preterm live birth and 24 patients were term live birth. The total number of newborns were 33. Two fetuses suffered neonatal intracranial hemorrhage and died after birth. Thirty-one fetuses were alive and born without any abnormity.Conclusion:For pregnant women with high risk of cardiovascular disease and classified as mWHO pregnancy risk level Ⅳ, cardiopulmonary bypass and interventional therapy during pregnancy could be used as an alternative for better materal and fetal outcomes.
